Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Village malaria workers for the community-based management of vivax malaria

Journal article

Adhikari B. et al, (2023), The Lancet Regional Health - Southeast Asia, 9, 100128 - 100128

WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria

Journal article

Peto TJ. et al, (2023), Transactions of The Royal Society of Tropical Medicine and Hygiene

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

Journal article

Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90

Stopping prereferral rectal artesunate — a grave error

Journal article

Watson JA. et al, (2022), BMJ Global Health, 7, e010006 - e010006

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Journal article

van der Pluijm RW. et al, (2022), The Lancet Infectious Diseases, 22, 765 - 766

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria

Journal article

Taylor WR. et al, (2021), Malaria Journal, 20

Load More